Cuba

Reimbursed Care Access

Cuba maintains a stringent, prohibition‑oriented approach to psychoactive and psychedelic substances: classical serotonergic psychedelics (psilocybin, MDMA, DMT, 5‑MeO‑DMT, mescaline, 2C‑X, ibogaine, ayahuasca) are treated under strict national drug‑control and penal provisions with no routine medical reimbursement or licensed therapeutic programs. Ketamine is an established anaesthetic and is controlled within the national psychopharmaceutical regime; esketamine (Spravato) has no public record of national marketing/coverage in Cuba. Access to non‑approved psychedelics is limited to tightly regulated research if it exists, otherwise prosecution applies under Cuba’s drug laws and court rulings on synthetic/controlled substances.